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ABSTRACT Time-dependent effects of cysteine modification were compared in skeletal ryanodine receptors (RyRs) from
normal pigs and RyRMH (Arg
615 to Cys615) from pigs susceptible to malignant hyperthermia, using the oxidizing reagents
4,4-dithiodipyridine (4,4-DTDP) and 5,5-dithio-bis(2-nitrobenzoic acid) (DTNB) or the reducing agent dithiothreitol (DTT).
Normal and RyRMH channels responded similarly to all reagents. DTNB (1 mM), either cytoplasmic (cis) or luminal (trans), or
1 mM 4,4-DTDP (cis) activated RyRs, introducing an additional long open time constant. 4,4-DTDP (cis), but not DTNB,
inhibited channels after 5 min. Activation and inhibition were relieved by DTT (1–10 mM). DTT (10 mM, cytoplasmic or
luminal), without oxidants, activated RyRs, and activation reversed with 1 mM DTNB. Control RyR activity was maintained
with 1 mM DTNB and 10 mM DTT present on the same or opposite sides of the bilayer. We suggest that 1) 4,4-DTDP and
DTNB covalently modify RyRs by oxidizing activating or inhibiting thiol groups; 2) a modified thiol depresses mammalian
skeletal RyR activity under control conditions; 3) both the activating thiols and the modified thiols, accessible from either
cytoplasm or lumen, reside in the transmembrane region; 4) some cardiac sulfhydryls are unavailable in skeletal RyRs; and
5) Cys615 in RyRMH is functionally unimportant in redox cycling.
INTRODUCTION
Contraction of striated muscle depends on Ca2 release
from the sarcoplasmic reticulum (SR), through ryanodine
receptor (RyR) calcium release channels. Oxidants are im-
portant ligands in the physiological activity of RyRs and act
by oxidation of free sulfhydryl (SH) groups, because their
effects are prevented by sulfhydryl reducing agents (Boraso
and Williams, 1994; Favero et al., 1995; Abramson et al.,
1995). Oxidants activate and can inhibit RyRs (Holmberg et
al., 1991; Holmberg and Williams, 1992; Boraso and Wil-
liams, 1994; Favero et al., 1995; Stoyanovsky et al., 1997).
Oxidation-induced activation proceeds under in vivo con-
ditions, in the presence of glutathione (GSH) (Koshita et al.,
1993), and is enhanced during ischemia or reperfusion, in
which oxygen free radicals increase and the ratio of GSH:
GSSG falls (Sies et al., 1972; Curello et al., 1985).
Reagents that react specifically with free SH groups are
used as model compounds to look at the effects of oxidation
and the importance of cysteine residues in RyR channel
function. Reactive disulfides 4,4- or 2,2-dithiodipyridine
(4,4-DTDP or 2,2-DTDP) activate and then block cardiac
RyRs when applied to the cytoplasmic (cis) side of the
channels (Eager et al., 1997; Eager and Dulhunty, 1998).
Skeletal RyRs have also been reported to be activated, but
not inhibited, by cis 4,4- or 2,2-DTDP and by GSSH
(Nagura et al., 1988; Marengo et al., 1998) and to be
inhibited by the reducing agents GSH, dithiothreitol (DTT),
or -mercaptoethanol (BME). The domain of the RyR on
which oxidants act is not clear. Both lipid-soluble and
water-soluble reagents can partition into the membrane, to a
greater or lesser extent, depending on their pKa values and
could react with -SH groups on either the side to which they
are added or in the transmembrane parts of the RyR protein.
It is unlikely that reagents would act rapidly on the opposite
side of the bilayer, because reagent crossing the bilayer
would be diluted in the large volume of the opposite solu-
tion and would take a long time to reach activating concen-
trations. Water-soluble oxidants appear to react with SH
groups only in the cytoplasmic or transmembrane domains
of the mammalian RyRs. Methanethiosulfonate derivatives
block skeletal muscle RyRs only from the cis side (Quinn
and Ehrlich, 1997). Some residues (-aSH and -iSH) respon-
sible for activation or inhibition of cardiac RyRs are acces-
sible to thimerosal from either side of the bilayer and are
located in the transmembrane domain, while other activat-
ing (-a*SH) residues are confined to the cytoplasmic domain
(Eager and Dulhunty, 1999). There have been no similar
reports of the long-term effects of thiol-specific oxidizing
agents added to the luminal or cytoplasmic sides of mam-
malian skeletal RyR channels.
The present study examines the effects on single skeletal
RyRs of long exposure to 2–10 mM concentrations of the
thiol-specific 4,4-DTDP or 5,5-dithiobis-(2Nitrobenzoic
acid) (DTNB) or DTT. The experiments tested the hypoth-
esis that, as in cardiac RyRs (Eager et al., 1999), three
classes of -SH (-aSH and -iSH, within the transmembrane
domain, or -a*SH in the cytoplasmic domain) are available
in skeletal RyRs for oxidation by specific sulfhydryl re-
agents. It was possible that the same thiols could be oxi-
dized in cardiac and skeletal RyRs, because 71 of 80
cysteine residues are conserved between the two isoforms
(Otsu et al., 1990). The experiments tested an additional
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hypothesis that the Arg615-to-Cys615 substitution in RyRMH
from pigs susceptible to malignant hyperthermia (MH) pro-
vides an additional -SH group for oxidation. MH is an
inherited skeletal muscle disorder, characterized by in-
creased Ca2 release from SR (Ohta et al., 1989; Carrier et
al., 1991; Mickelson and Louis, 1996) and reduced inhibi-
tion of RyRs by Ca2 (Fill et al., 1991; Shomer et al., 1993)
or Mg2 (Laver et al., 1997).
Novel findings are 1) that the water-soluble DTNB (in
either cis or trans solutions) and the lipid-soluble 4,4-
DTDP (in the cis solution) activate skeletal RyRs in a
similar way; 2) 4,4-DTDP added to the cis solution, but not
DTNB (cis or trans), inhibits skeletal RyRs after5 min; 3)
in the absence of an oxidizing reagent, 10 mM DTT acti-
vates skeletal RyRs from the cis or trans solution; 4) “con-
trol-like” channel activity is maintained when 1 mM DTNB
and 10 mM DTT are present together on either the same or
opposite sides of the bilayer; and 5) effects of oxidation and
reduction are the same in normal RyRs and RyRMH. Our
conclusions are that 1) -aSH is located in the skeletal RyR
transmembrane domain, as in cardiac RyRs; 2) -a*SH, in
cardiac RyRs, is not available for oxidation in skeletal
RyRs; 3) a modified thiol in the transmembrane domain
(-abS-R, where R is either a protein S if the modified thiol
is a disulfide, or an N if the modified group is nitrosylated;
Xu et al., 1998) normally suppresses skeletal RyR activity;
and 4) the Arg615-to-Cys615 substitution in MH does not
provide an additional SH group for oxidation by thiol-
specific reagents.
MATERIALS AND METHODS
Biological material and caffeine-halothane
contracture test for MH susceptibility
The methods for genetic testing, muscle dissection, caffeine-halothane
contracture testing, preparation of SR vesicles, and single-channel record-
ing have been described previously (Otsu et al., 1992; Owen et al., 1997;
Laver et al., 1997). Muscle and blood samples were obtained from three
homozygous normal pigs (one Belgium Landrace and two Landrace) and
three homozygous MH pigs (two Belgium Landrace and one Landrace)
aged 4 months. Each animal was genetically tested for a normal or MH
RyR allele (containing either Arg615 or Cis615). The SR preparations were
from the same animals as those used in Laver et al. (1997). The description
of anesthetic techniques, muscle dissection, and halothane/caffeine con-
tracture tests are given by Laver et al. (1997). All fiber bundles from the
three homozygous normal animals failed to respond to halothane or 2 mM
caffeine, while all fiber bundles from the three homozygous MH animals
developed tension in response to both drugs.
Isolation of SR vesicles
The preparation of crude SR vesicles was based on the methods of
Meissner (1984) and Ma et al. (1995). The freshly dissected back and leg
muscle was washed in cold phosphate-buffered saline containing 2 mM
EGTA (pH 7.0), trimmed of fat and connective tissue, cubed, and either
frozen in liquid N2 and stored at 70°C or freshly processed. The fresh or
thawed muscle cubes were suspended in (mM) 5 Tris maleate, 100 NaCl,
2 EDTA, 0.1 EGTA (pH 6.8) (5 ml/g of tissue). The muscle was homog-
enized in a Waring blender in four 15-s high-speed bursts. The homogenate
was centrifuged at 2600  g for 30 min, and the supernatant ws filtered
through cotton gauze and centrifuged at 10,000  g for 30 min. The pellet
(P2) was collected, and the supernatant was centrifuged again at 35,000 
g and the pellet (P3) collected. Pellets P2 and P3 were resuspended in
(mM) 5 Tris-2-(N-morpholino)ethanesulfonic acid (Tris-MES), 300 su-
crose, 100 KCl, 2 DTT (pH 6.8). Aliquots of the suspensions were frozen
in liquid nitrogen and stored at 70°C. All buffers contained the protease
inhibitors phenylmethylsulfonyl fluoride (0.7 mM), leupeptin (1 g/ml),
pepstatin A (1 M), and benzamidine (1 mM).
Lipid bilayer techniques
The lipid bilayer and single-channel recording technique are described by
Ahern et al. (1994) and Laver et al. (1995). Bilayers were formed from
phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine
(5:3:2 w/w) (Avanti Polar Lipids, Alabaster, AL) across an aperture with a
diameter of 200–250 m in the wall of a 1.0-ml Delrin cup (Cadillac
Plastics, Australia). TC vesicles (final concentration 10 g/ml) were added
to the cis chamber and stirred until vesicle incorporation was observed. The
cytoplasmic side of channels incorporated into the bilayer faced the cis
solution. The bilayer potential was controlled and single-channel activity
was recorded with an Axopatch 200A amplifier (Axon Instruments, Foster
City, CA). For experimental purposes, the cis chamber was held at ground
and the voltage of the trans chamber was controlled. Bilayer potential is
expressed in the conventional way as Vcis Vtrans (i.e., Vcytoplasm Vlumen).
Bilayers were formed and vesicles incorporated into the bilayer, using
cis and trans solutions containing (mM) 230 Cs methanesulfonate (CsMS),
20 CsCl, 0.1 CaCl2, and 10 N-tris[hyroxymethyl]methyl-2-aminoethane-
sulfonic acid (TES) (pH 7.4 adjusted with CsOH). The cis solution also
contained 500 mM mannitol to aid SR vesicle fusion and RyR incorpora-
tion into the bilayer.
Recording and analysis of single-channel data
Channel activity was recorded at40 mV. In general activity was recorded
for a 2-min control period before and 1 min after 0.5-s voltage pulses to
40 mV. Drugs were then added to either the cis or trans chamber with a
10-s stirring period, and then activity was recorded for several minutes.
Voltage pulses to 40 mV were occasionally applied to the bilayer after
drug addition to determine whether channels could be activated by the
change in bilayer potential. Because RyR channel activity can increase
immediately after a voltage pulse (Zahradnikova and Meszaros, 1998;
Laver and Lamb, 1998), the first 30 s after each voltage pulse was excluded
from analysis.
Channel activity was filtered at 1 kHz (10-pole low-pass Bessel,3 dB)
and digitized at 2 kHz. Analysis of single-channel records (using Channel
2, written by P. W. Gage and M. Smith) yielded channel open probability
(Po), frequency of events (Fo), open times, closed times, and mean open or
closed times (To or Tc), as well as mean current (I). The open discriminator
was set at 25% of the maximum current, and the closed discriminator at
50% of the open discriminator, so that openings to both subconductance
and maximum conductance levels were included in the analysis. Single-
channel parameters were measured during the 30 s, showing maximum I
during the control period and then the period of maximum I after the
addition of drugs. Dwell-time distributions were plotted as the frequency of
openings in logged bins (Sigworth and Sine, 1987) to display the large
range of open times seen in control recordings and after the addition of
oxidizing reagents. The fit of a multiple exponential function to the data
was assessed using a least-squares fit.
Statistics
Average data are given as mean SEM. The significance of the difference
between control and test values was evaluated with a Student’s t-test, either
one or two sided and for independent or paired data, as appropriate.
Differences were considered to be significant when p  0.05.
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RESULTS
Effects of DTNB or 4,4-DTDP on normal RyRs
Activation by DTNB
RyRs from homozygous normal pig muscle were activated
by addition of the hydrophilic DTNB (1 mM) to either the
cis or trans chamber. Control RyR activity was character-
ized by brief openings to the maximum conductance and to
lower conductance levels (Figs. 1, A and B, and 2, A and B).
Longer openings appeared with DTNB (Figs. 1 A and 2 B).
Channel activity increased with a delay of 1 min after
DTNB was added to the cis chamber in 13 of 14 channels,
with a delay of 3 min after trans DTNB was added to 10
of 11 RyRs. Average mean current (I) increased from a
control value of1.43 0.12 pA to3.91 0.19 pA (n	
10) or from 2.73  0.38 pA to 5.81  0.64 pA (n 	 6).
When the average ratio of mean current before and after
addition of the drugs for individual channels was deter-
mined, there was an approximately fivefold increase with
cis DTNB and an approximately threefold increase with
trans DTNB (Table 1). Note that the delay was assessed by
eye from channel records. The numbers of channels for I in
Table 1 are fewer than the number for the delay because I
was measured using Channel2 analysis of low-noise record-
ings only.
Channel activity with 1 mM cis DTNB was not altered by
subsequent addition of 2 mM cis DTT (Results below) but
returned toward control when 10 mM DTT was added to the
cis side of nine of nine RyRs activated by cis DTNB or to
the trans side of three of three RyRs activated by trans
DTNB (Figs. 1 and 2). This fall in activity was presumably
due to reduction of -SH groups oxidized by DTNB, because
DTT (10 mM cis or trans) added without DTNB activated
RyRs (Results below). The similar magnitude and time
course of effects of cis or trans DTNB support the hypoth-
esis that DTNB oxidizes -aSH, located in the transmem-
brane domain.
FIGURE 1 Activation of normal RyRs by 1 mM DTNB or 1 mM
4,4-DTDP added to the cis chamber and reversal of activation by DTT.
Channel activity in this and subsequent figures was recorded at 40 mV
with symmetrical 250 mM Cs and 100 M Ca2. (A) A single RyR under
control conditions (I), during activation by 1 mM cis DTNB (II) and then
after addition of 10 mM DTT to the cis chamber (III). (B) A single RyR
under control conditions (I), during activation by 1 mM cis 4,4-DTDP,
added from a 10 mM stock dissolved in cis solution (II), and then after the
addition of 2 mM DTT to the cis chamber (III). The zero current level is
indicated by solid lines, and the maximum open conductance is shown by
broken lines.
FIGURE 2 Inhibition of normal RyRs by 1 mM cis 4,4-DTDP, but not
by 1 mM trans DTNB. (A) A bilayer containing one RyR channel under
control conditions (I), activation 3 min after the addition of 1 mM cis
4,4-DTDP dissolved in ethanol (II), inhibition 10 min after the addition of
4,4-DTDP (III), and recovery from inhibition after a final addition of 2
mM DTT (IV). (B) A bilayer containing two normal RyR channels with
only one channel active under control conditions (I), increased activity in
one channel 3 min after the addition of 1 mM trans DTNB (II), two
channels active after a 10-min exposure to trans DTNB (III), and return to
control activity in one channel after a final addition of 10 mM DTT (IV).
The zero current level is indicated by solid lines, and the maximum open
conductance is shown by dotted lines.
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Activation by 4,4-DTDP
4,4-DTDP (1 mM cis added in ethanol, 1% v/v) caused an
approximately sevenfold increase in I, which began 2
min after its addition to 15 of 15 channels (Table 1). In
contrast to sheep cardiac (Eager et al., 1997) or rabbit
skeletal (Ahern et al., 1997a) RyRs, 1% ethanol (alone)
increased I after 3 min in eight of eight RyRs (Table 1).
Therefore 4,4-DTDP was dissolved in cis solution at 10
mM and added to the cis chamber to a final concentration of
1 mM. In this situation, I increased in 18 of 21 channels,
after a delay of 1.5 min (Table 1). Activity returned
toward control after 2 mM cis DTT addition to each of four
single 4,4-DTDP-activated RyRs (Figs. 1 B and 2 A). Thus
4,4-DTDP also activated RyRs via oxidation of -SH
groups, which could also be -aSH in the transmembrane
domain.
Inhibition by 4,4-DTDP
Cis 4,4-DTDP (1 mM) abolished activity in seven of 10
RyRs, after 334  52 s (4,4-DTDP plus ethanol, Fig. 2
AIII), or in five of nine channels after 456  82 s (4,4-
DTDP added in cis solution). Inactivated channels were not
reactivated by four pulses to 40 mV (0.03 Hz). Infrequent
activity remained in seven of 19 channels, for 26 min in one
case. RyRs were not inactivated after 5–30 min with 1%
ethanol alone (n 	 9). Cis DTT (2 mM) restored activity
after 129  62 s in three of five RyRs inactivated by
4,4-DTDP plus ethanol (Fig. 2 AIV) or after 240 165 s in
three of five RyRs inactivated by 4,4-DTDP alone. Recov-
ery with DTT shows that inactivation is due to -SH oxida-
tion and that -iSH is present in skeletal RyRs and accessible
to DTT. In contrast to 4,4-DTDP, 1 mM DTNB (either cis
or trans) did not inactivate RyRs after 5–20 min (Fig. 2 B,
II and III). If activity fell, it increased again after pulses to
40 mV.
Comparison of RyR and RyRMH
The characteristics of normal RyRs and RyRMH (from ho-
mozygous MH pigs) were similar under control conditions
at 40 mV, with 100 M Ca2 and symmetrical 250 mM
CsMS (Fig. 3). Single-channel conductance was 452 9 pS
(n 	 4) for normal RyRs and 470  11 pS (n 	 5) for
RyRMH, and control I for RyRMH was 1.76 0.13 pA (n	
39), compared with 2.1 pA for 16 normal RyRs (Results
above). In addition, both types of channel were 1) locked
into a submaximum conductance state with 10–15 M cis
ryanodine (RyR, n 	 11; RyRMH, n 	 12), 2) blocked by 5
TABLE 1 Average effect of drugs on mean current, I, in normal RyRs (normal) and RyRMH (MH)
Normal MH
Idrug/Icontrol (n) Delay [s] (n) Idrug/Icontrol (n) Delay [s] (n)
DTNB (cis) 5.28  1.47** (10) 68  13 (13) 3.91  0.92** (9) 198  38## (14)
DTNB (trans) 2.87  0.73** (6) 207  50 (10) 4.70  1.42** (9) 141  25 (16)
DTDP (ethanol) 6.56 3.34** (12) 138  48 (15) 4.22  1.53* (7) 214  35 (8)
Ethanol (1%) 2.65 1.03* (5) 168  21 (8) 1.79  0.51 (6) 150  13 (5)
DTDP (H2O) 3.41  1.64* (8) 100  15 (18) 3.02  0.87 (13) 156  27 (13)
Relative changes in I (Idrug/Icontrol) are shown. DTNB and 4,4-DTDP (DTDP) were added to a final concentration of 1 mM. Data are given as mean 
1 SEM.
Idrug is significantly different from Icontrol with: *p 
 0.05. **p 
 0.01.
Idrug/Icontrol for RyRMH is significantly different from Idrug/Icontrol for normal RyRs with: ##p 
 0.01.
DTDP (ethanol), DTDP dissolved in ethanol.
DTDP (H2O), DTDP dissolved in cis solution.
FIGURE 3 RyRMH is activated by 1 mM cis DTNB and 1 mM cis
4,4-DTDP. (A) A single RyRMH under control conditions (I) and during
activation by 1 mM cis DTNB (II), and recovery after the addition of 10
mM DTT to the cis chamber (III). (B) A single RyRMH under control
conditions (I), during activation by 1 mM cis 4,4-DTDP, and added from
a 10 mM stock dissolved in cis solution (II), and recovery after the addition
of 2 mM DTT to the cis chamber (III). The zero current level is indicated
by solid lines, and the maximum open conductance is shown by the broken
lines.
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M cis ruthenium red (RyR, n 	 3; RyRMH, n 	 2), and 3)
activated by 5 mM ATP (RyR, n 	 4; RyRMH, n 	 5).
Effects of reactive disulfides on RyRs from
MH pigs
Activation by DTNB or 4,4-DTDP
Activity increased fourfold in 14 of 14 RyRMH channels3
min after the addition of 1 mM cis DTNB or approximately
fourfold in 16 of 17 channels 2 min after trans DTNB
(Fig. 3, Table 1). Activation of RyRMH by cis DTNB was
significantly slower than activation of normal RyRs (p 

0.01). There were no other differences in activation by
DTNB between normal RyRs and RyRMH. 4,4-DTDP
added to RyRMH, with ethanol or alone (in cis solution),
induced three- to fourfold increases in average I (Fig. 3),
after 2.5–3.5 min, while ethanol alone caused an approxi-
mately twofold increase in I after 2.5 min (Table 1).
RyRMH activity returned to control levels within 1 min after
10 mM DTT was added to the cis side of channels activated
by cis DTNB (four of four) or trans DTNB (three of three)
or after 2 mM cis DTT was added to cis 4,4-DTDP-
activated channels (five of five). The similar results with
normal RyRs and RyRMH show that the Arg
615-to-Cys615
substitution in MH does not alter the ability of sulfhydryl-
specific reagents to activate RyRs by oxidizing -aSH. The
differences between RyRMH and normal RyRs in the rate of
activation by cis DTNB could be explained by structural
changes that reduce the accessibility of -aSH in RyRMH.
Inhibition of RyRMH
RyRMH channels were inactivated after 458  30 s expo-
sure to 1 mM cis 4,4-DTDP (added with 1% ethanol, n 	
10), and nine of the 10 channels were reactivated 160 30 s
after adding 2 mM DTT. Similarly, 1 mM cis 4,4-DTDP
added alone (in cis solution) abolished RyRMH activity in
three of six channels after 383  156 s, and the three
channels recovered 50  26 s after 2 mM DTT was added.
No RyRMH channels were inhibited during 3.5–32-min ex-
posure to DTNB (cis or trans, n 	 13) or 4–30-min expo-
sure to 1% cis ethanol (n 	 5). Thus inhibition of RyR
channels via oxidation of -iSH was not altered by the MH
mutation.
There were some curious exceptions to the general ob-
servations reported above. One normal and two RyRMH
channels were inactivated 2–7 min after 4,4-DTDP was
added, without initial activation, and inhibition was relieved
40–90 s after cis DTT was added. This confirmed indepen-
dent channel activation and inhibition and supported sepa-
rate -aSH and -iSH residues (see also Eager et al., 1998).
Activity in three RyRMH and two normal RyRs fell after
initial activation by cis 4,4-DTDP, and activity in two
normal RyRs fell 5 min after cis 4,4-DTDP was added,
without any initial activation. There was no further change
in activity in these seven channels when 2 mM cis DTT was
added, suggesting that the disulfide formed upon exposure
to 4,4-DTDP (-aS-Sr, where -Sr is contributed either by the
reactive disulfide or by the channel protein) was reduced
during exposure to 4,4-DTDP and hence that the affinity of
-aSH for 4,4-DTDP in these channels was less than normal.
Single-channel properties of RyR and RyRMH
There was no significant difference between normal RyR
(n 	 48) and RyRMH (n 	 45) in the steady-state parameter
values for Po, Fo, To, and Tc measured over 30-s periods
(Table 2). The two types of channel showed similar modes
of activity, transitions between modes and responses to
voltage pulses to 40 mV (Fig. 4). Predominant modes
were either low activity or high activity, unaltered after the
voltage pulse (Fig. 4, I and II) or voltage-activated increase
in activity immediately after the voltage pulse, which then
decayed after 10–20 s to a lower level that was also seen
before the voltage pulse (Fig. 4 III). Strong submaximum
conductance activity was also seen in both normal RyRs and
TABLE 2 Effects of oxidizing reagents and ethanol on single-channel parameters open probability (P0), mean open time (T0),
mean closed time (Tc), and frequency of openings (F0)
Condition
(n (normal, MH))
P0 T0 (ms) Tc (ms) F0 (s1)
Normal MH Normal MH Normal MH Normal MH
Control (8, 9) 0.15  0.04 0.20  0.06 1.17  0.07 2.75  0.12 8.82  1.08 12.41  1.03 97  19 71  17
DTNB (cis) 0.27  0.05* 0.41  0.06** 5.26  0.81** 6.68  0.22** 11.22  1.22 11.19  1.24 62  21 64  10
Control (6, 6) 0.23  0.06 0.25  0.08 1.65  0.10 5.35  0.71 6.55  0.77 13.27  0.98 139  31 60  14
DTNB (trans) 0.48  0.12** 0.56  0.09** 4.72  0.72* 11.46  1.17** 5.74  0.97 8.39  0.82* 125  34 64  16
Control (6, 6) 0.32  0.13 0.19  0.06 2.57  0.40 2.02  0.15 5.62  0.70 11.75  2.24 88  18 95  24
DTDP (eth) 0.67  0.13* 0.38  0.11 13.23  3.35** 5.85  0.78* 5.83  1.58 10.17  1.55 74  24 73  18
Control (4, 5) 0.24  0.08 0.38  0.12 1.86  0.26 3.43  0.50 6.43  0.75 6.60  1.18 125  18 113  28
Ethanol (1%) 0.44  0.10* 0.49  0.12 4.10  0.69* 4.13  0.43* 4.65  0.57 4.52  0.57 118  22 119  14
Control (7, 5) 0.17  0.06 0.20  0.07 1.20  0.19 1.05  0.57 7.65  1.26 4.15  1.81 72  17 78  31
DTDP (H2O) 0.42  0.11* 0.40  0.09* 8.32  2.37** 2.59  1.06 9.84  2.78 6.87  8.50 50  17 86  26
DTNB and 4,4-DTDP (DTDP) were added to a final concentration of 1 mM. Results are given as mean  1 SEM.
Significant differences between parameters under control conditions and after addition of the reagent are indicated by: *p 
 0.05. **p 
 0.01.
DTDP (ethanol), DTDP dissolved in ethanol.
DTDP (H2O), DTDP dissolved in cis solution.
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RyRMH (Fig. 4, C and D), giving an average open channel
conductance that was 0.50  0.05 of the maximum conduc-
tance in normal RyRs or 0.37  0.09 in RyRMH.
Effects of oxidizing reagents and ethanol on single-channel
parameters of normal RyRs and RyRMH
The oxidizing reagents increased mean open time (To) in all
normal RyRs and all RyRMH channels, with significant
increases in average To under most conditions (Table 2).
The effect on other aspects of channel activity was complex,
with an increase in mean closed time (Tc) in some channels
and a decrease in Tc in others, so that the changes in average
Fo and Po were not significant (Table 2).
DTT at 10 mM reversed the effects of DTNB, and at 2
mM reversed the effects of 4,4-DTDP in normal RyRs and
RyRMH. Data were pooled from the few channels that were
suitable for analysis and were exposed first to an oxidizing
reagent and then to DTT. I, Po, and To fell significantly
after DTT was added to the oxidation-activated channels
(Fig. 5). The similar actions of cis DTNB, trans DTNB, and
cis 4,4-DTDP on the single-channel parameters during
activation and the similar reversal of these actions by DTT
provide further evidence that one class of cysteine residues
(-aSH) is oxidized in each of the three situations.
The average open channel conductance was higher after
oxidation, being 0.50  0.05 of the maximum conductance
before and 0.57 0.09 after oxidation in normal RyRs (n	
25), or 0.37  0.05 before and 0.49  0.06 after in RyRMH
(n 	 24, pooled data for cis DTNB, trans DTNB, and cis 4,
4-DTDP), although the increase was significant only in
RyRMH. This suggests that there was an increased fraction
of openings to the maximum conductance and to higher
submaximum conductance levels after oxidation-induced
activation.
Effects of DTNB and 4,4-DTDP on open and
closed time distributions
Open times for normal RyR and RyRMH fell into two
exponential components under control conditions and three
exponential components after oxidation-induced activation
(Figs. 6 and 7). Closed times for both normal RyRs and
RyRMH channels fell into three exponential components
under control conditions and after oxidiation-induced acti-
vation. Data for normal RyRs and RyRMH were combined
(Fig. 7) because there were no consistent differences in the
average time constants or probability of events between the
two channel types. Under control conditions and during
oxidation-induced activation, the shortest open time con-
stant, o1, was 1–2 ms, and the second time constant, o2,
was 7–13 ms. The longest time constant, o3, was seen only
in “activated” channels; it was 50–100 ms and contained

10% of openings. The increase in To was largely due to
the appearance of o3.
Closed time constants under control and oxidation-in-
duced activation conditions were c1 (2–4 ms), c2 (9–23
ms), and c3 (90–480 ms) (Figs. 6 and 7). The longest
component (c3) contained very few events and did not
change in any consistent way during oxidation-induced
activation. The similar open and closed time distributions
with cis DTNB, trans DTNB, and cis 4,4-DTDP are con-
sistent with the hypothesis that the same cysteine residues
are oxidized with each reagent. An additional fourth long
open time constant in cardiac RyRs exposed to cis 4,4-
DTDP (Eager et al., 1999) was not seen in skeletal RyRs.
FIGURE 4 Modes of activity and openings to submaximum conductance
levels in normal RyRs and RyRMH. (A and B) Examples of channels
showing low activity before and after a voltage pulse to 40 mV (I), high
activity before and after a pulse to 40 mV (II), or low activity before and
high activity after the voltage pulse (III). (A) Normal RyRs. (B) RyRMH. (C
and D) A single normal RyR and single RyRMH, respectively, both show-
ing long openings to a submaximum conductance level. The zero current
level is indicated by solid lines, and the maximum open conductance is
shown by dotted lines.
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An effect of oxidizing reagents on burst behavior
Channel openings in 20–50% of normal or RyRMH channels
under control conditions was continuous, while activity in
the other channels was clustered into bursts, separated by
closures of 0.5–60 s (not included in Figs. 6 and 7). Con-
tinuous or burst activity was observed in each of the three
modes (high, low, or voltage-activated activity) defined in
the text description of Fig. 4 (I–III) above. When either 1
mM DTNB or 1 mM 4,4-DTDP was added to the cis
chamber, 97% of channels adopted burst behavior, in addi-
tion to the increase in channel open time (Table 3). Only
59% of normal RyRs or RyRMH had burst behavior with
trans DTNB-induced activation, or 45% during activation
with cis or trans DTT (10 mM, Results below) or with
ethanol (Table 3). The stabilization of burst behavior by
oxidizing reagents in the cis chamber was not reversed by
DTT. Bursting behavior remained in 94% of channels when
10 mM DTT was added to the cis or trans bath after 1 mM
cis DTNB, and remained in 50% of channels when 10 mM
DTT was added to the trans bath after 1 mM trans DTNB.
This effect of oxidizing reagents on burst activity sug-
gested that DTNB and 4,4-DTDP modified a site on the
cytoplasmic side of the channel that alters channel gating to
stabilize bursting behavior. It is unclear whether the effect is
due to -SH oxidation or an interaction between the oxidizing
reagents and other sites on the channel, because the effect
was not reversed by DTT.
Further evidence that -aSH is located in the
transmembrane domain
If the hypothesis that -aSH is located in the transmembrane
domain and is accessible from either side of the bilayer is
correct, then activation by DTNB on one side of the bilayer
should be reversed by adding DTT to the opposite chamber.
In this experiment, five of six RyR channels were activated
when DTNB was added to the cis chamber, and activity fell
in five of the channels when DTT was added to the trans
FIGURE 5 Effects of DTNB (cis or trans) or cis 4,4-DTDP on average
channel parameters and reversal of the effects by DTT. Average relative
changes are shown for a subset of channels that were exposed first to an
oxidizing reagent (light gray bins) and then to DTT (dark gray bins).
Pooled data from normal RyRs and RyRMH are shown. Channels were
exposed to (A) 1 mM cis DTNB and then 10 mM cis DTT (n 	 6), (B) 1
mM trans DTNB and then 10 mM trans DTT (n 	 4); (C) 1 mM cis
4,4-DTDP (added in cis solution) and then 2 mM DTT (n 	 4). Channels
were exposed to DTT 2–3 min after exposure to DTNB or 4,4-DTDP, at
times when channel activity was high. Single-channel parameters shown
are mean current (I), open probability (Po), mean open time (To), fre-
quency of opening (Fo), and mean closed time (Tc). The bins show mean
values and the vertical lines indicate 1 SEM. Asterisks indicate the
significance of differences of test data from control (during activation) or
from the activated level (after the addition of DTT). * p 
 0.05; ** p 

0.01.
FIGURE 6 Effect of 1 mM cis DTNB on open and closed time distri-
butions for a single RyRMH. Open and closed times are collected into
logged bins, and the square root of the relative frequency of events (f 1/2) is
plotted against the logarithm of the open or closed times in ms. (A) Open
time distribution. (B) Closed time distribution. In A and B, distributions are
shown for control data (I) and during activation by 1 mM cis DTNB (II).
The continuous lines in each graph show the multiple exponential function
fitted to the data, and the broken lines show the individual exponential
components (2 in AI and 3 in each of AII and BI&II).
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chamber. Conversely, one of three other channels was ac-
tivated when DTNB was added to the trans chamber, and
activity fell in that channel when DTT was added to the cis
chamber.
Evidence for a modified thiol in the
transmembrane domain
DTT at 2 mM, added in the absence of an oxidizing reagent,
did not significantly alter RyR activity. The mean current,
normalized to control, was 3.6  2.8 in five normal RyRs
after 2 mM DTT addition and 2.7  0.4 in five RyRMH
channels. On the other hand, 10 mM DTT significantly
activated normal RyRs and RyRMH when added to either the
cis or trans chamber in the absence of added oxidizing
reagent; activity then fell toward control levels when 1 mM
DTNB was added to the opposite side of the bilayer (Fig. 8).
Cis DTT (10 mM) activated five of five RyRs (two normal;
three RyRMH), while trans DTT activated two of four nor-
mal RyRs and three of three RyRMH. Data from normal
RyRs and RyRMH is combined in Fig. 8. The two RyRs not
activated by trans DTT were not included, because their
control activity was high (I of 4.0 and 6.8 pA) and outside
the range of 0.2–1.2 pA in the other five channels. Average
I increased significantly with 10 mM DTT (cis or trans)
and then fell significantly after DTNB addition to the op-
posite chamber (Fig. 9). Interestingly, activity in the two
channels that were not activated by cis DTT fell to lower
levels when DTNB was added to the trans chamber, with
similar approximately sixfold reductions in I. These chan-
nels may have already been in a reduced state before the
addition of DTT.
These results suggest that a class of modified thiol (-abS-
R-, where R is either a protein S if the modified thiol is a
disulfide, or a N if the modified group is nitrosylated; Xu et
al., 1998) is available to 10 mM DTT from either the cis or
trans chamber and that the reduced -abSH can be oxidized
by DTNB from the opposite side of the bilayer. The acces-
FIGURE 7 Effects of oxidizing reagents on the average
time constants and fraction of events obtained from mul-
tiple exponential fits to the open and closed time distri-
butions (e.g., Fig. 6). The probability of events falling into
each time constant (p) is plotted against the logarithm of
the time constant in ms (log [open time, ms] or log [closed
time, ms]). The average values are for combined data from
normal RyRs and RyRMH. (A) Open time constants. (B)
Closed time constants. In A and B data are shown before
and after the addition of 1 mM cis DTNB (I); 1 mM trans
DTNB (II); 1 mM cis 4,4-DTDP with 1% ethanol or cis
1% ethanol alone (III); 1 mM cis 4,4-DTDP (IV). Aver-
age values are shown for control conditons (f, ) and in
the presence of the oxidizing reagent () or ethanol (ƒ,
AIII and BIII only).
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sibility from either side of the bilayer indicates that -abS-R-
and -abSH are located in the transmembrane domain.
“Control-like” channel activity is retained in the
presence of 1 mM DTNB plus 10 mM DTT
Channel activity returned to “control-like” levels when 10
mM DTT and 1 mM DTNB were present on either the same
or opposite sides of the bilayer. This was confirmed in
further experiments, in which the “control-like” activity was
maintained if 10 mM DTT was present on both sides of the
channel, with 1 mM DTNB on one side only (five of six
experiments with cis DTNB, or three of three with trans
DTNB). Average I measured in four of the channels with
cis DTNB or two of the channels with trans DTNB was
2.19  0.32 pA. “Control-like” activity was retained
when 10 mM DTT was removed from one chamber, leaving
10 mM DTT and 1 mM DTNB in the cis chamber in two
cases, or in the trans chamber in a third case (I 	 1.33
0.51 pA).
The assertion that channel activity in the presence of 10
mM DTT and 1 mM DTNB was “control-like” was sup-
ported by a final experiment (n 	 2) in which the trans
chamber initially contained 1 mM DTNB plus 10 mM DTT
and the cis chamber contained 1 mM DTNB (I 	 0.97 
0.39 pA). The trans chamber was perfused with normal
trans solution, leaving 1 mM DTNB in the cis solution. In
both cases, RyR activity increased after perfusion, as it
usually did when DTNB was present alone in the cis cham-
ber (I 	 5.50  0.33 pA).
DISCUSSION
We found that DTNB activated skeletal muscle RyRs from
either the cytoplasmic or luminal side of the channel, while
4,4-DTDP activated and then inhibited RyRs from the
cytoplasmic solution. Activation by both reagents and inhi-
bition by 4,4-DTDP were reversed by DTT and thus are
due to sulfhydryl oxidation. The results can be explained by
oxidation of two classes of sulfhydryl, -aSH in the trans-
membrane domain for activation or -iSH in a hydrophobic
environment for inhibition. Separate -aSH and -iSH residues
have also been postulated for cardiac RyRs (Eager and
Dulhunty, 1998, 1999). Additional novel findings were that
1) addition of the oxidizing reagents to the cis side of RyRs
stabilized bursting channel activity, suggesting that cyto-
plasmic residues regulate burst activity; 2) addition of 10
mM DTT to either side of the channel caused activation,
which was reversed when DTNB was added to the opposite
side, suggesting that a modified thiol -abS-R- in the trans-
membrane domain normally inhibits activity; and 3) “con-
trol-like” channel activity was maintained in the presence of
1 mM DTNB and 10 mM DTT. Finally, the effects of the
oxidizing reagents on RyRs from normal and MH pigs were
similar.
Activation of skeletal RyRs by reactive disulfides
Activation of skeletal RyRs by DTNB and 4,4-DTDP con-
firms previous reports on skeletal RyRs (Nagura et al.,
1988; Marengo et al., 1998; Zable et al., 1997). Similar
activation, with a long time constant component introduced
into the open time distribution, is seen in cardiac RyRs
exposed to 4,4-DTDP or thimerosal. An increase in open
frequency is also seen in cardiac RyRs. A fourth long time
constant component in the open time distribution of cardiac
RyRs oxidized by 4,4-DTDP was not seen in skeletal
RyRs, suggesting that the -a*SH class of sulfhydryl, postu-
lated for the cardiac RyR (Eager and Dulhunty, 1998),
either is not present or is not available for oxidation in














Normal RyR 0 8 10 0
RyRMH 0 2 16 0
DTNB (trans)
Normal RyR 8 0 4 1
RyRMH 3 0 15 1
4,4-DTDP (eth) (cis)
Normal RyR 0 6 9 1
RyRMH 0 1 13 0
4,4-DTDP (H2O) (cis)
Normal RyR 2 3 18 0
RyRMH 0 0 17 0
Ethanol (1%) (cis)
Normal RyR 1 1 7 1
RyRMH 0 1 13 1
Oxidizing reagents were added to a final concentration of 1 mM. The numbers of channels are shown with continuous or bursting activity before and after
addition of the agents listed on the left-hand side, for normal RyRs and RyRMH.
4,4-DTDP (eth), 4,4-DTDP dissolved in ethanol.
4,4-DTDP (H2O), 4,4-DTDP dissolved in cis solution.
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skeletal RyRs. The fact that reversal of activation by 1 mM
DTNB required 10 mM DTT, while reversal of activation
by 4,4-DTDP or thimerosal requires 2 mM DTT (results
above and Eager et al., 1999), suggests that DTNB has
stronger oxidative properties than 4,4-DTDP. The failure
of GSSG to activate skeletal RyRs from the luminal solution
(Zable et al., 1997) might have been due to the weak
oxidizing ability of GSSG.
What do similar changes to reagents added to
either side of the RyR mean in terms of the
location of target residues?
The ability of DTNB to activate RyRs from the luminal or
cytoplasmic side and the reversal of activation by 10 mM
DTT added to the opposite side of the channel suggest that
-aSH is accessible to DTNB and DTT from the cytoplasmic
and luminal solutions. This accessibility to water-soluble
reagents could suggest that target residues are located in the
channel pore. However, DTT with a pKa of 9.0–10 (Shaked
et al., 1980) would be largely uncharged at pH 7.4 and
would rapidly partition into the membrane. Similarly,
1–10% of DTNB with a pKa of 5–6 (Houk et al., 1987)
would enter the membrane. Thus the water-soluble agents
could access residues located in the transmembrane domain,
not in the pore, although activating residues in a transmem-
brane, rather than pore location, would see only 10–100 M
DTNB. This is not an unreasonable [DTNB] for activation,
because DTNB is a strong oxidizing reagent (above), and
NO at 40 nM nitrosylates thiol groups and activates
skeletal RyRs (Hart and Dulhunty, unpublished observa-
tions), while cardiac RyRs are activated by 100 M 4,4-
DTDP (Eager et al., 1997).
It is unlikely that the reagents, either crossing the mem-
brane or passing through the pore, could have targeted
residues located on the opposite side of the channel and
remote from the membrane, because dilution in the large
volume of solution would mean that it would take a long
time for their concentrations to increase to active levels.
Thus activation with DTNB or recovery with DTT would
FIGURE 8 Activation of normal RyRs and RyRMH by 10 mM DTT
added to the cis or trans chamber without oxidizing reagent, and the
reversal of activation by the addition of 1 mM DTNB to the opposite
chamber. (A and C) Normal RyRs. (B and D) RyRMH. Records in A–D
show control activity (I); activity with 10 mM DTT (II); activity after
addition of 1 mM DTNB (III). Drug additions were (A and B) cis DTT then
trans DTNB and (C and D) trans DTT then cis DTNB. The zero current
level is indicated by solid lines, and the maximum open conductance is
shown by broken lines. Bilayers in A, B, and D contained one active
channel, while the bilayer in C contained three active channel. The three
broken lines in C indicate the maximum open conductance with one, two,
or three channels open in the bilayer.
FIGURE 9 Average effects on I of activation by 10 mM DTT added to
the cis or trans chamber and reversal of the activation when 1 mM DTNB
is added to the opposite chamber. The cross-hatched bins show results for
cis DTT followed by trans DTNB. The stippled bins show data results for
trans DTT followed by cis DTNB. The average I (in pA) is given for
control conditions (control), after the addition of DTT (DTT), and then
after the addition of DTNB (DTNB). Asterisks indicate the significance of
the difference between DTT and control, or between DTNB and DTT.
* p 
 0.05; ** p 
 0.01.
Haarmann et al. Oxidation and Reduction of Skeletal RyRs 3019
have been faster when the reagents were applied to the side
of the channel containing the residues. Because similar rates
of activation and deactivation were seen with cis and trans
applications of both reagents, we conclude that DTNB and
DTT act at a transmembrane (possibly pore) location.
Another possibility is that separate actions of DTNB on
cytoplasmic and luminal sulfhydryls result in similar func-
tional effects on RyR activity (Eager et al., 1998). However,
reversal of activation by DTT on the opposite side of the
bilayer would not be expected if -aSH were distributed over
the luminal and cytoplasmic domains of the RyR. If -aSH is
located in the channel pore, then DTT, DTNB, and 4,4-
DTDP must penetrate the channel. Molecules of a mass
similar to that of DTT (formula weight, FW 154) and
4,4-DTDP (FW 220), such as glucose and xylose (FW 180
and 150, respectively), pass slowly through skeletal RyRs
(Meissner, 1986; Kasai et al., 1992). DTNB (FW 396) and
thimerosal (FW 405) have a greater mass but may never-
theless assume conformations that allow them to also pass
through the channel. Curiously, neither DTNB nor 4,4-
DTDP nor DTT blocks the channel into the low-conduc-
tance states seen in the presence of the smaller (FW 110–
172) methanethiosulfonate (MTS) derivatives (Quinn and
Ehrlich, 1997). Although DTNB and 4,4-DTDP are
cleaved during oxidation of protein thiols, their half-masses
of 110 and 198 remain equivalent to that of the MTS
compounds. If DTT, DTNB, and 4,4-DTDP enter the pore
and interact with sulfhydryl residues to alter channel gating,
they must do so without physically blocking the pore.
Inhibition of skeletal RyRs by reactive disulfides
We propose that oxidation of separate -aSH and -iSH leads,
respectively, to activation and inhibition of RyRs, rather
than oxidation of one class of sulfhydryl that first activates
and then inhibits the channel. Evidence for separate residues
is that 1) activation by DTNB was not followed by inhibi-
tion and 2) inhibition was observed without preceding ac-
tivation in some channels (see also Eager et al., 1997). RyR
inhibition by 4,4-DTDP, but not DTNB, suggested that
-iSH may be located in a domain of the skeletal RyR that is
inaccessible to DTNB. In contrast, the water-soluble thimer-
osal inhibited cardiac RyRs (Eager et al., 1999). This ap-
parent difference may have been due to the use of thimer-
osal in cardiac and DTNB in skeletal RyRs, because
thimerosal penetrates proteins more effectively than other
thiol reagents (van Iwaarden et al., 1992).
An alternative possibility is that the different abilities of
DTNB, 4,4-DTDP, and thimerosal to inhibit RyRs are
related to their different redox potentials. Sulfhydryl-spe-
cific oxidizing reagents can react with proteins in two steps
(Glazer, 1970). The first step is the formation of a mixed
disulfide between the protein thiol (-aSH, for example) and
the reagent (rS-Sr):
-aSH  rS-Sr7 -aS-Sr  rSH
The reaction can then proceed under appropriate conditions,
to cross-link -aS- with another thiol group within the protein
(-iSH, for example):
-aS-Sr  -iSH7 aS-Si-  rSH
In this case the cross-linking step would be responsible for
inhibition. The second step may proceed with weak oxidiz-
ing reagents like 4,4-DTDP and thimerosal, but not with
stronger oxidants like DTNB. Stronger oxidation by DTNB
is supported by the fact that 10 mM DTT is required to
reduce -aS-Sr when the oxidizing agent is 1 mM DTNB,
while the thiols oxidized by 1 mM 4,4-DTDP or thimerosal
are reduced by 2 mM DTT. The hypothesis that inhibition
depends on the formation of a disulfide bridge requires
separate -aSH and -iSH residues but does not explain the
observation that inhibition can proceed in the absence of
activation (discussed above).
Comparison between cardiac and skeletal RyRs
It is possible that the same cysteine residues form -aSH in
cardiac and skeletal RyRs. Many cysteine residues in the
channel domain are conserved between cardiac and skeletal
RyRs (Otsu et al., 1990) and are in an appropriate location
for -aSH. The subtly different effects of oxidation on the
gating of the cardiac and skeletal RyRs could be attributed
to a difference in the connections between the -aSH and the
channel gating mechanisms. Such a difference may be im-
posed by sequence differences between the cardiac and
skeletal RyRs (having only 66% sequence identity; Otsu et
al., 1990), which could impose structural differences be-
tween the proteins.
Skeletal RyR channels recovered from inhibition when
DTT was added to the cis solution, but the loss of activity
in cardiac RyRs could not be reversed by DTT (Eager et al.,
1997). Inhibition of skeletal RyRs by NO is also relieved by
DTT (Hart and Dulhunty, unpublished observations). These
observations suggest that the oxidized xS-Si- (where -xS is
contributed either by DTNB or 4,4-DTDP or by the pro-
tein) is more accessible to DTT in skeletal RyRs than in
cardiac RyRs.
Effect of DTT alone on pig skeletal RyRs
Addition of 10 mM DTT to either side of the bilayer (with
oxidizing reagents absent from cis and trans solutions)
increased RyR activity. Increased mammalian skeletal RyR
activity with DTT is in contrast to a fall in Po when 20 mM
GSH was added to frog skeletal or rabbit cardiac RyRs
(Marengo et al., 1998) or when 10 mM DTT was added to
sheep cardiac RyRs (Eager et al., 1997). Zable et al. (1997)
also showed a reduction in rabbit skeletal RyR activity with
6–10 mM GSH and reduced ryanodine binding with GSH,
DTT, and BME. The reason for the difference between our
results and those of Zable et al. may be partly due to
sequence differences between pig and rabbit RyRs (see
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below). However, we also find that rabbit skeletal RyR
activity increases when 2 mM DTT alone is added to the
trans chamber (Green, Hart, and Dulhunty, unpublished
observations). In agreement with our findings, DTT induces
contraction in intact frog skeletal muscle fibres by trigger-
ing Ca2 release from SR (Oba et al., 1996).
Activation of skeletal RyRs by cis or trans DTT and its
reversal with DTNB in the opposite chamber suggest that a
class of modified thiols, -abS-R-, which normally suppresses
channel activity, is present in the mammalian skeletal RyR
transmembrane region. The R group could be contributed
either by another protein cysteine if a disulfide is formed or
could be a N if -abS is nitrosylated. Cardiac RyRs contain
stable nitrosothiols if isolated in the absence of DTT, and
nitrosylated thiols can be denitrosylated by 10 mM DTT
(Xu et al., 1998). The pig SR used in the present experi-
ments was isolated in the presence of 2 mM DTT, which
may not have denitrosylated all nitrosothiols on the RyRs.
Denitrosylation, however, is difficult to reconcile with the
reversibility of the effects of DTT by DTNB, unless it is
also suggested that modification per se depresses channel
activity, independent of whether the thiol is nitrosylated or
oxidized by DTNB. It seems more likely that the modified
thiol is part of an intraprotein disulfide bridge.
Two cysteine residues in the skeletal RyR, one just out-
side the M1 region and one between M5 and M6, are not
present in cardiac RyRs (Otsu et al., 1990). These cysteines
are likely to be in the transmembrane region and could form
disulfide bridges or be available for S-nitrosylation.
“Control-like” channel activity with 1 mM DTNB and 10
mM DTT
The observation that channel activity returned to “control-
like” levels when 1 mM DTNB and 10 mM DTT were
present, either on the same or opposite sides of the bilayer,
provided further evidence that -aSH and -abS-R- are located
in the transmembrane domain. The fact that removal of
DTT, leaving only DTNB in one chamber, resulted in
channel activation, which was similar to that seen when
DTNB was added alone, supported the suggestion that chan-
nel activity was “control-like” when the two reagents were
present together. The result suggests that redox cycling with
1 mM DTNB plus 10 mM DTT kept -abS-R- mostly in its
modified form, and -aSH mostly in its reduced form.
Effect of ethanol on the RyRs from pig muscle
Activation of normal RyRs and RyRMH by 1% ethanol after
2–3 min was unexpected because exposure to ethanol for
the same period does not alter single-channel activity of
cardiac (Eager et al., 1997) or rabbit skeletal (Ahern et al.,
1997b) RyRs. However, open times increase if rabbit skel-
etal RyRs are exposed to ethanol for 5 min (Dulhunty and
Curtis, unpublished observations). The results may reflect
intrinsic differences between pig and rabbit skeletal RyRs
reported previously. The maximum rate of polylysine-in-
duced Ca2 release is four times greater in pig skeletal SR
than that in rabbit SR (El-Hayek et al., 1995; Cifuentes et
al., 1989). In addition, pig RyRs are less sensitive than
rabbit RyRs to activation by peptides corresponding to the
loop between membrane-spanning segments II and III of the
skeletal DHPR (Gallant, Pace, and Dulhunty, 1999). These
functional differences are likely to be imposed by sequence
differences between the pig and rabbit RyRs. There are 45
residues (two cysteines) that differ between the pig and
rabbit RyRs in the first 1500 residues of the protein, with an
overall 3% dissimilarity (Fujii et al., 1991).
Effect of the RyR mutation in malignant hyperthermia
RyRMH responded to oxidation and reduction in a way
similar to that of normal RyRs. Therefore the additional
cysteine residue in MH does not alter the response of the
RyR to either oxidizing or reducing reagents. Either Cis615
is buried in the protein and is not accessible to the redox
reagents, or oxidation/reduction of the additional -SH or
-S-R- does not effect channel activity under the conditions
of our experiments. The response of RyRs to oxidation can
depend on ligands bound to the protein (Eager et al., 1998;
Xu et al., 1998); thus it remains possible that Cis615 in
RyRMH becomes available for oxidation or reduction, or
that the modified residue is able to regulate activity, during
increased Ca2 release and increased metabolic activity,
and can thus further enhance Ca2 release from the SR
during the MH response.
In conclusion, the similar effects of oxidizing reagents in
cardiac and skeletal RyRs suggest that at least two of the
cysteine residues whose modification alter channel gating
are conserved between the two proteins. The results further
suggest that free -SH residues and modified thiols are
present in the transmembrane region of the skeletal RyR
under control conditions and that their covalent modifica-
tion under oxidizing or reducing conditions can signifi-
cantly modify RyR channel gating.
The authors are grateful to Suzi Pace and Joan Stivala for their assistance
in the preparation of SR vesicles from normal and MH pigs. The isolation
of the vesicles, caffeine/halthane testing, and genetic testing were done in
collaboration with Drs. Virginia Owen, Pauline Junankar, Derek Laver,
Graham Lamb, Nicole Taske, and Paul Foster (Laver et al., 1997).
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